Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9MTX

CryoEM structure of extracellular domain of human HER2 complexed with nano-bodies 29E09

9MTX の概要
エントリーDOI10.2210/pdb9mtx/pdb
EMDBエントリー48615
分子名称Nanobody VHH 29E09, receptor protein-tyrosine kinase (2 entities in total)
機能のキーワードnanobodies, vhh, her2, complex, cancer, transferase
由来する生物種Lama glama (llama)
詳細
タンパク質・核酸の鎖数2
化学式量合計82768.55
構造登録者
Bruch, E.M.,Rak, A. (登録日: 2025-01-12, 公開日: 2025-11-19, 最終更新日: 2026-01-21)
主引用文献De Tavernier, E.,Kim, P.S.,Bruch, E.M.,Cortez-Retamozo, V.F.,Timmerman, L.,Flynn, A.L.,Van Overbeke, W.,Tirode, F.,Cintra Barbosa-Lorenzi, V.,Piepenhagen, P.,Dinh-Le, T.,Luna, E.,Li, A.,Baker, A.,Rak, A.,Pao, L.I.,Vintem, A.P.B.
TPP-45142-an Anti-HER2 T cell Engager-Designed for Selective HER2-Low Cancer Immunotherapy.
Mol.Cancer Ther., 2026
Cited by
PubMed Abstract: The standard of care for patients with HER2-positive cancers is well established, but a significant unmet need exists for patients with HER2-low tumors, who do not meet the eligibility criteria for trastuzumab, and for patients with HER2-positive tumors, who are refractory to trastuzumab treatment. Therefore, in this study, we developed a NANOBODY® domain-based HER2-targeting, T cell receptor (TCR)αβ-based T cell engager (TCE) molecule-TPP-45142; it recognizes a HER2 epitope distinct from that recognized by trastuzumab and pertuzumab and redirects T cells to kill HER2-low cancers such as breast, gastric, and gastroesophageal junction adenocarcinoma (GEJ) cancers. TPP-45142 mediated potent T cell-dependent cytotoxicity against HER2-low cancer cell lines in vitro and inhibited in vivo tumor growth of HER2-low breast cancer xenografts. TPP-45142 was highly selective toward tumor cells expressing low HER2 levels than toward normal cardiac cells and exhibited a favourable therapeutic index as per a cytokine release assay. Thus, TPP-45142, with an improved safety profile, is a promising next-generation TCE for treating challenging HER2-low cancers.
PubMed: 41504346
DOI: 10.1158/1535-7163.MCT-25-0654
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.06 Å)
構造検証レポート
Validation report summary of 9mtx
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon